Embargoed until 3 p.m. Pacific Time 6 p.m. Eastern Time, Thursday, Jan. 25, 2018

LOS ANGELES, Jan. 25, 2018 — A simple finger-to-nose test by medical professionals almost doubled the recognition of possible stroke involving the circulation at the back of the brain, according to preliminary research presented at the American Stroke Association’s International Stroke Conference 2018, a world premier meeting dedicated to the science and treatment of cerebrovascular disease for researchers and clinicians.

Posterior strokes represent up to a quarter of all stroke admissions to the hospital, but there are often delays in diagnosis because the patients may not have the typical stroke signs included in screening tools used by emergency medical technicians (EMTs).

In a new study, researchers compared the recognition of posterior strokes between EMTs who received standard training in stroke screening with EMTs who received standard training plus in-person training in the “finger-to-nose test.” In this simple coordination test the patient alternates touching their own nose and the examiner’s finger. Performance can be impaired in posterior stroke.

The researchers found:

  • After training including the finger-to-nose test, EMTs recognized 12 of 16 (75 percent) posterior strokes, compared with 9 of 26 (38 percent) in the 12 months prior to training.

  • After routine training (not including the finger-to-nose test), EMTs recognized 13 of 28 (46 percent) posterior strokes, compared with 10 of 36 (28 percent) in the 12 months prior to training, an improvement that was not statistically significant.

The Midwest Affiliate of the American Heart Association (American Heart Association Mentored Clinical & Population Research Award) funded the study.

John A. Oostema, M.D., Michigan State University, College of Human Medicine, Grand Rapids, Michigan.

Note: Scientific presentation is 5:15 p.m. PT, Thursday, Jan. 25, 2018.

Presentation location: Hall H

Additional Resources:

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.


About the American Stroke Association

The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit StrokeAssociation.org. Follow us on Facebook and Twitter.

For Media Inquiries and AHA Spokesperson Perspective:

AHA News Media in Dallas: 214-706-1173

AHA News Media Office, Jan. 24-26, 2018 at the Los Angeles Convention Center: 213-743-6262

For Public Inquiries: 800-AHA-USA1 (242-8721)

heart.org and strokeassociation.org